PATENT CLAIM ANALYSIS

Application Number: 16025579
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-10
Patent Classification: ["514", "638000"]

Abstract:
A method for reducing macrophage migration inhibitory factor (MIF or MMIF) cytokine or its biological activity, including the step of administering an isothiocyanate functional surfactant to a patient having a disease or condition wherein MIF cytokine or its biological activity is implicated in the disease or condition. In one embodiment, the protonated form of the isothiocyanate functional surfactant is represented by the following chemical structure:

Claim (Index 3):
The method according to  claim 1 , wherein the isothiocyanate functional surfactant comprises a lysine derivative, wherein the lysine derivative comprises an \u03b1-nitrogen and a 6-nitrogen, and wherein an alkyl and/or alkanoyl substituent comprising at least approximately 8 carbon atoms is associated with the \u03b1-nitrogen, and further wherein at least one isothiocyanate functional group is associated with the 6-nitrogen.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 95.0
- Lexical Diversity: 1.44898
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16025386', '16025640', '14519510', '15792097', '14868959']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8060656128537305
- 35 USC 102 Novelty (BERT): 0.6041490957849439
- Combined Prediction Score: 0.7858739611468518
- Mean Citation Score: 507.7980799999999
- Max Citation Score: 522.5349
- Similarity Product: 486.1991498725355

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test